S&P 500   4,505.10 (-1.57%)
DOW   34,345.05 (-0.85%)
QQQ   380.36 (-2.45%)
AAPL   160.21 (-2.17%)
MSFT   320.44 (-2.75%)
FB   304.09 (-2.03%)
GOOGL   2,819.17 (-1.40%)
AMZN   3,358.96 (-2.28%)
TSLA   1,013.91 (-6.52%)
NVDA   303.94 (-5.39%)
BABA   112.13 (-8.09%)
NIO   31.84 (-12.04%)
CGC   9.96 (-3.86%)
AMD   142.07 (-5.71%)
GE   92.06 (-3.33%)
MU   80.97 (-2.30%)
T   23.39 (+1.48%)
F   19.02 (-4.28%)
DIS   144.59 (-1.77%)
PFE   54.23 (+2.24%)
AMC   25.55 (-15.62%)
ACB   5.76 (-6.19%)
BA   196.06 (-3.12%)
S&P 500   4,505.10 (-1.57%)
DOW   34,345.05 (-0.85%)
QQQ   380.36 (-2.45%)
AAPL   160.21 (-2.17%)
MSFT   320.44 (-2.75%)
FB   304.09 (-2.03%)
GOOGL   2,819.17 (-1.40%)
AMZN   3,358.96 (-2.28%)
TSLA   1,013.91 (-6.52%)
NVDA   303.94 (-5.39%)
BABA   112.13 (-8.09%)
NIO   31.84 (-12.04%)
CGC   9.96 (-3.86%)
AMD   142.07 (-5.71%)
GE   92.06 (-3.33%)
MU   80.97 (-2.30%)
T   23.39 (+1.48%)
F   19.02 (-4.28%)
DIS   144.59 (-1.77%)
PFE   54.23 (+2.24%)
AMC   25.55 (-15.62%)
ACB   5.76 (-6.19%)
BA   196.06 (-3.12%)
S&P 500   4,505.10 (-1.57%)
DOW   34,345.05 (-0.85%)
QQQ   380.36 (-2.45%)
AAPL   160.21 (-2.17%)
MSFT   320.44 (-2.75%)
FB   304.09 (-2.03%)
GOOGL   2,819.17 (-1.40%)
AMZN   3,358.96 (-2.28%)
TSLA   1,013.91 (-6.52%)
NVDA   303.94 (-5.39%)
BABA   112.13 (-8.09%)
NIO   31.84 (-12.04%)
CGC   9.96 (-3.86%)
AMD   142.07 (-5.71%)
GE   92.06 (-3.33%)
MU   80.97 (-2.30%)
T   23.39 (+1.48%)
F   19.02 (-4.28%)
DIS   144.59 (-1.77%)
PFE   54.23 (+2.24%)
AMC   25.55 (-15.62%)
ACB   5.76 (-6.19%)
BA   196.06 (-3.12%)
S&P 500   4,505.10 (-1.57%)
DOW   34,345.05 (-0.85%)
QQQ   380.36 (-2.45%)
AAPL   160.21 (-2.17%)
MSFT   320.44 (-2.75%)
FB   304.09 (-2.03%)
GOOGL   2,819.17 (-1.40%)
AMZN   3,358.96 (-2.28%)
TSLA   1,013.91 (-6.52%)
NVDA   303.94 (-5.39%)
BABA   112.13 (-8.09%)
NIO   31.84 (-12.04%)
CGC   9.96 (-3.86%)
AMD   142.07 (-5.71%)
GE   92.06 (-3.33%)
MU   80.97 (-2.30%)
T   23.39 (+1.48%)
F   19.02 (-4.28%)
DIS   144.59 (-1.77%)
PFE   54.23 (+2.24%)
AMC   25.55 (-15.62%)
ACB   5.76 (-6.19%)
BA   196.06 (-3.12%)
NYSE:QGEN

QIAGEN News Headlines

$54.32
-0.24 (-0.44%)
(As of 12/3/2021 02:58 PM ET)
Add
Compare
Today's Range
$53.73
$54.85
50-Day Range
$50.62
$56.47
52-Week Range
$45.58
$59.00
Volume
26,045 shs
Average Volume
807,177 shs
Market Capitalization
$12.38 billion
P/E Ratio
21.22
Dividend Yield
N/A
Beta
0.24

Media Mentions By Week



QIAGEN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

QGEN
News Sentiment

0.25

0.32

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

QGEN Articles
This Week

20

6

QGEN Articles
Average Week

Get QIAGEN News Delivered to You Automatically

Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter.

QIAGEN (NYSE:QGEN) News Headlines Today

SourceHeadline
marketbeat.com logoQIAGEN (NYSE:QGEN) Lowered to Hold at Kepler Capital Markets
marketbeat.com - November 27 at 11:14 PM
businesswire.com logoQIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19 - Business Wire
businesswire.com - December 2 at 8:21 AM
finance.yahoo.com logoQIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19
finance.yahoo.com - December 2 at 8:21 AM
businesswire.com logoResolve Biosciences Appoints Oliver Dick as Chief Operating Officer - Business Wire
businesswire.com - December 1 at 9:47 AM
investors.com logoIBD Rating Upgrades: Qiagen Shows Improved Relative Price Strength - Investor's Business Daily
investors.com - November 29 at 2:20 PM
MarketBeat logoQIAGEN (NYSE:QGEN) Shares Gap Down to $56.47
americanbankingnews.com - November 29 at 11:02 AM
nasdaq.com logoQiagen Reaffirms Effectiveness of PCR Tests on Omnicron Variant - Nasdaq
nasdaq.com - November 29 at 9:20 AM
businesswire.com logoQIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS - Business Wire
businesswire.com - November 29 at 9:20 AM
finance.yahoo.com logoQIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS
finance.yahoo.com - November 29 at 9:20 AM
finance.yahoo.com logoQIAGEN reaffirms effectiveness of its SARS-CoV-2 PCR tests in light of the new coronavirus variant B.1.1.529 - Yahoo Finance
finance.yahoo.com - November 28 at 12:13 AM
MarketBeat logoQIAGEN (NYSE:QGEN) Downgraded by Kepler Capital Markets to "Hold"
americanbankingnews.com - November 27 at 11:14 PM
nasdaq.com logoQiagen Reaffirms Effectiveness Of Its Covid PCR Tests Amid Detection Of New Variant In South Africa - Nasdaq
nasdaq.com - November 27 at 9:12 AM
barrons.com logoCovid Testing Company Says PCR Tests Are Effective Against New Covid Variant - Barron's
barrons.com - November 27 at 12:15 AM
finance.yahoo.com logoCovid Testing Company Says PCR Tests Are Effective Against New Covid Variant
finance.yahoo.com - November 26 at 7:14 PM
benzinga.com logoQIAGEN Reaffirms Effectiveness Of Its SARS-CoV-2 PCR Tests In Light Of New Coronavirus Variant B.1.1.529 - Benzinga
benzinga.com - November 26 at 1:41 PM
businesswire.com logoQIAGEN reaffirms effectiveness of its SARS-CoV-2 PCR tests in light of the new coronavirus variant B.1.1.529 - Business Wire
businesswire.com - November 26 at 1:41 PM
finance.yahoo.com logoQIAGEN reaffirms effectiveness of its SARS-CoV-2 PCR tests in light of the new coronavirus variant B.1.1.529
finance.yahoo.com - November 26 at 1:41 PM
finance.yahoo.com logoQiagen Rises as It Reaffirms PCR Tests’ Effectiveness in Light of New Covid Variant
finance.yahoo.com - November 26 at 1:41 PM
MarketBeat logoQIAGEN (NYSE:QGEN) Shares Gap Up to $54.56
americanbankingnews.com - November 26 at 11:52 AM
businesswire.com logoGlobal Sequencing Reagents Market (2021 to 2028) - Featuring Agilent Technologies, BGI Genomics and Qiagen Among Others - ResearchAndMarkets.com - Business Wire
businesswire.com - November 19 at 7:21 PM
seekingalpha.com logoQiagen falls after report not in talks with suitors - Seeking Alpha
seekingalpha.com - November 17 at 2:02 PM
MarketBeat logoQIAGEN (NYSE:QGEN) Sees Unusually-High Trading Volume
americanbankingnews.com - November 17 at 12:38 PM
MarketBeat logoQIAGEN (NYSE:QGEN) Releases FY 2021 Earnings Guidance
americanbankingnews.com - November 17 at 8:14 AM
MarketBeat logoQIAGEN (NYSE:QGEN) Issues Q4 2021 Earnings Guidance
americanbankingnews.com - November 17 at 8:14 AM
MarketBeat logoQIAGEN (NYSE:QGEN) Shares Gap Up to $53.40
americanbankingnews.com - November 16 at 10:54 AM
seekingalpha.com logoQiagen rises amid rumors of fresh takeover bid - Seeking Alpha
seekingalpha.com - November 16 at 8:56 AM
MarketBeat logoQIAGEN (NYSE:QGEN) Updates FY 2021 Earnings Guidance
americanbankingnews.com - November 10 at 7:14 AM
MarketBeat logo$0.61 EPS Expected for QIAGEN (NYSE:QGEN) This Quarter
americanbankingnews.com - November 9 at 7:14 PM
businesswire.com logoQIAGEN Commits to Reduce Carbon Emissions by Setting Science-Based Target to Reach Net Zero by 2050 - Business Wire
businesswire.com - November 9 at 2:31 PM
finance.yahoo.com logoQIAGEN Commits to Reduce Carbon Emissions by Setting Science-Based Target to Reach Net Zero by 2050 - Yahoo Finance
finance.yahoo.com - November 8 at 6:51 PM
businesswire.com logoQIAGEN and BD Settle Patent Infringement Lawsuit - Business Wire
businesswire.com - November 6 at 12:00 AM
finance.yahoo.com logoQIAGEN and BD Settle Patent Infringement Lawsuit - Yahoo Finance
finance.yahoo.com - November 5 at 6:59 PM
finance.yahoo.com logoQIAGEN and BD Settle Patent Infringement Lawsuit
finance.yahoo.com - November 5 at 6:59 PM
bloomberg.com logoA Merger Between Covid Testers Risks a False Positive - Bloomberg
bloomberg.com - November 5 at 8:57 AM
benzinga.com logoQiagen Clocks 17% Increase In Non-COVID Product Sales; Raises FY21 Guidance - Benzinga
benzinga.com - November 4 at 8:36 PM
fool.com logoQiagen NV (QGEN) Q3 2021 Earnings Call Transcript - Motley Fool
fool.com - November 4 at 3:35 PM
finance.yahoo.com logoQIAGEN (QGEN) Q3 Earnings Surpass Estimates, 2021 View Up
finance.yahoo.com - November 4 at 3:35 PM
finance.yahoo.com logoQiagen NV (QGEN) Q3 2021 Earnings Call Transcript
finance.yahoo.com - November 4 at 3:35 PM
nasdaq.com logoQiagen (QGEN) Q3 Earnings and Revenues Top Estimates - Nasdaq
nasdaq.com - November 4 at 10:35 AM
nasdaq.com logoQIAGEN (QGEN) Q3 Earnings Surpass Estimates, 2021 View Up - Nasdaq
nasdaq.com - November 4 at 10:35 AM
finance.yahoo.com logoQiagen Clocks 17% Increase In Non-COVID Product Sales; Raises FY21 Guidance
finance.yahoo.com - November 4 at 10:35 AM
nasdaq.com logoQiagen Raises FY21 Outlook - Nasdaq
nasdaq.com - November 4 at 12:54 AM
finance.yahoo.com logoQiagen (QGEN) Q3 Earnings and Revenues Top Estimates
finance.yahoo.com - November 4 at 12:54 AM
finance.yahoo.com logoQIAGEN Reports Strong Results for Third Quarter and First Nine Months Of 2021
finance.yahoo.com - November 3 at 7:54 PM
seekingalpha.com logoQIAGEN, bioMérieux said to be eyeing combination - Seeking Alpha
seekingalpha.com - November 3 at 9:51 AM
bloomberg.com logoDiagnostics Firms Qiagen, BioMerieux Said to Explore Tie-Up - Bloomberg
bloomberg.com - November 3 at 9:51 AM
finance.yahoo.com logoDiagnostics Firms Qiagen, BioMerieux Said to Explore Tie-Up
finance.yahoo.com - November 3 at 9:51 AM
businesswire.com logoGlobal Helicobacter Pylori Diagnostics Market (2021 to 2025) - Featuring Abbott Laboratories, bioMerieux and QIAGEN Among Others - ResearchAndMarkets.com - Business Wire
businesswire.com - November 2 at 11:15 PM
businesswire.com logoQIAGEN expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2 - Business Wire
businesswire.com - November 2 at 11:15 PM
finance.yahoo.com logoQIAGEN expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2 - Yahoo Finance
finance.yahoo.com - November 2 at 6:15 PM
finance.yahoo.com logoQIAGEN expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2
finance.yahoo.com - November 2 at 6:15 PM
Get QIAGEN News Delivered to You Automatically

Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.